Montelukast Prescribing at GLEBE HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
817
Total Quantity
24.0K
NHS Cost
£1.1K
vs National Avg
+19.3%
GLEBE HOUSE SURGERY prescribed 817 items of Montelukast over the last 12 months at a cost of £1,137 to the NHS. This is 19.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
64
Jul 2026
82
Jul 2026
54
Jul 2026
79
Jul 2026
56
Jul 2026
73
Jul 2026
61
Jul 2026
66
Jul 2026
82
Jul 2026
63
Jul 2026
69
Jul 2026
68
Prescribing Details
| Total Items | 817 |
|---|---|
| Total Quantity | 24,040 |
| Total NHS Cost | £1,137 |
| Presentations | 3 different forms |
| vs National Average | +19.3% |
Montelukast Prescribing Comparison
| This practice | 817 items |
|---|---|
| National average per practice | 685 items |
| Difference | +19.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.